
STABILITY AND CHARACTERIZATION
Our integrated research, formulation, product development, and manufacturing teams work closely together to anticipate challenges that hinder global accessibility and availability of critical immune-enhancing products. AAHI’s product development and characterization team links research and formulation to development of novel vaccines and immunotherapeutic products that can be manufactured at commercial scale and remain stable at room or refrigerated temperatures for years.

PRODUCT DEVELOPMENT:
STABILITY STUDIES:

CHARACTERIZATION OF SMALL MOLECULES, MACROMOLECULE, AND VACCINE ADJUVANT FORMULATIONS
ANALYTICAL ASSAY DEVELOPMENT
Development of analytical assays to characterize the material of interest, including HPLC assays, ELISA, and other biophysical assays.
